Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

Carlsmed Appoints Richard Heppenstall as Chief Financial Officer

$CARLPress releaseSep 28, 2026, 8:30 AM ETRead the release

Carlsmed appointed Richard Heppenstall as CFO effective immediately, succeeding Leo Greenstein who is leaving after three years to pursue other interests. Heppenstall brings nearly 30 years of healthcare and tech finance experience, most recently as CFO of ZimVie through its October 2025 acquisition by ArchiMed.

Key figures

Guidance
FY2026 revenue guidance of $74 to $78 million reaffirmed, representing 50% growth over 2025 at the midpoint

AI analysis

Red flags1 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.